FDA-2013-P-0048-0009_Citizen_Petition_Denial_Response_from_FDA_CDER_to_.pdf
FDA-2013-P-0076-0008_Citizen_Petition_Denial_Response_from_FDA_CDRH_to_.pdf
FDA-2013-P-0119-0010_Interim_Response_Letter_from_FDA_CDER_to_Buchanan_.pdf
FDA-2013-P-0148-0006_Citizen_Petition_Denial_Response_from_FDA_CDER_to_.pdf
FDA-2013-P-0203-0004_Citizen_Petition_Denial_Response_from_FDA_CDER_to_.pdf
FDA-2013-P-0298-0007_Reconsideration_Letter_from_FDA_to_Yale_University.pdf
FDA-2013-P-0323-0004_Agency_Response_Letter_from_FDA_CDER_to_Rapid_Prec.pdf
FDA-2013-P-0608-0008_Agency_Response_Letter_from_FDA_CDER_to_Janssen_Re.pdf
FDA-2013-P-0885-0003_Interim_Response_from_FDA_CDER__to_AMAG_Pharmaceut.pdf
FDA-2013-P-0947-0003_Letter_from_FDA_CDER_to_Hyman_Phelps_and_McNamara_.pdf
FDA-2013-P-0990-0003_Letter_from_FDA_CDER_to_Corporate_Social_Responsib.pdf
FDA-2013-P-1055-0003_Interim_Response_from_FDA_CDER_to_Actavis_Elizabet.pdf
FDA-2013-P-1056-0004_Letter_from_FDA_CDER_to__Citizen_Petition.pdf
FDA-2013-P-1153-0017_Memorandum_of_Meeting_from_FDA_CDER_re_Meeting_wit.pdf
FDA-2013-P-1398-0013_Memorandum_of_Meeting_from_FDA_CDER_re_Meeting_wit.pdf
FDA-2013-P-1612-0408_Correction_from_FDA_DDM.pdf
FDA-2013-P-1636-0002_Acknowledgement_Letter_from_FDA_DDM_to_Lannett_Com.pdf
FDA-2013-P-1637-0004_Citizen_Petition_Approval_Letter_from_FDA_CDER_to_.pdf
FDA-2006-P-0001-0004_Letter_from_FDA_CDER_to_Michael_Bannester.pdf
FDA-2006-P-0007-0051_Petition_Partial_Approval_and_Denial_from_FDA_CDER.pdf
FDA-2006-P-0011-0002_Acknowledgement_Letter_from_FDA_DMB_to_King___Spal.pdf
FDA-2006-P-0016-0003_Letter_from_FDA_CDER_to_Mylan_Laboratories_Inc_.pdf
FDA-2006-P-0075-0003_Acknowledgment_Letter_from_FDA_DMB_to_Michael_Patt.pdf
FDA-2006-P-0077-0007_Memorandum_of_Withdrawal_from_FDA_CDER_to_DDM.pdf
FDA-2006-P-0080-0005_Letter_from_FDA_CDER_to_Foley___Lardner_LLP.pdf
FDA-2006-P-0151-0003_Acknowledgement_Letter_from_FDA_DMB_to_B__Braun_Me.pdf
FDA-2006-P-0203-0005_Interim_Response_from_FDA_CDER_to_Mylan_Pharmaceut.pdf
FDA-2006-P-0208-0006_Memo_response_from_FDA_CFSAN_to_Close_Citizen_Peti.pdf
FDA-2006-P-0212-0002_Acknowledgment_Letter_from_FDA_DMB_to_Monosol_Rx__.pdf
FDA-2006-P-0215-0005_Letter_from_FDA_CDER_to_West_ward_Pharmaceutical_C.pdf
FDA-2006-P-0265-0005_Interim_Response_Letter_from_FDA_CDER_to_B__Braum_.pdf
FDA-2006-P-0275-0006_Citizen_Petition_Denial_from_FDA_CDER_to_KV_Pharma.pdf
FDA-2006-P-0281-0002_Acknowledgement_Letter_from_FDA_DMB_to_Kendle_Inte.pdf
FDA-2006-P-0286-0002_Acknowledgment_Letter_from_FDA_DMB_to_Strides_Inc_.pdf
FDA-2006-P-0334-0004_Acknowledgment_Letter_from_FDA_DMB_to_Center_for_S.pdf
FDA-2006-P-0345-0005_Acknowledgment_Letter_from_FDA_DMB_to_King___Spald.pdf
FDA-2006-P-0387-0001_Acknowledgment_Letter_from_FDA_DMB_to_Orchid_Healt.pdf
FDA-2006-P-0389-0003_Acknowledgment_Letter_from_FDA_DMB_to_M__McDole.pdf
FDA-2006-P-0401-0002_Acknowledgment_Letter_from_FDA_DMB_to_Sicor_Pharma.pdf
FDA-2006-P-0442-0002_Acknowledgment_Letter_from_FDA_DMB_to_West_Ward_Ph.pdf
FDA-2006-P-0458-0007_Memorandum_of_Withdrawal_from_FDA_CDER_to_DDM.pdf
FDA-2006-P-0461-0015_Denial_of_Citizen_Petition_from_FDA_CDER_to_UCB__I.pdf
FDA-2006-P-0514-0002_Acknowledgement_Letter_from_FDA_DMB_to_Kirkpatrick.pdf
FDA-2006-P-0534-0004_Acknowledgment_Letter_from_FDA_DMB_to_B__Braun_Med.pdf
FDA-2006-P-0542-0004_Citizen_Petition_Denial_from_FDA_CDER_to_James_Q__.pdf
FDA-2020-P-0158-0002_Acknowledgment_Letter_from_FDA_DMS_to_Sidley_Austi.pdf
FDA-2020-P-0512-0002_Acknowledgment_Letter_from_FDA_DMS_to_Hyman__Phelp.pdf
FDA-2020-P-0513-0002_Acknowledgment_Letter_from_FDA_DMS_to_Foley_and_La.pdf
FDA-2020-P-0598-0002_Acknowledgment_Letter_from_FDA_DMS_to_Lachman_Cons.pdf
FDA-2020-P-0678-0005_Petition_Response_Letter_from_FDA_CDER_to_Freseniu.pdf
FDA-2020-P-0698-0012_Acknowledgment_Letter_from_FDA_DMS_to_Physicians_C.pdf
FDA-2020-P-0745-0004_Approval_Letter_from_FDA_CDER_to_Fox_Rothschild_LL.pdf
FDA-2020-P-0813-0005_Agency_Response_Letter_from_FDA_CDER_to_Unichem_Ph.pdf
FDA-2020-P-0863-0551_Request_for_Extension_from_FDA_CFSAN_to_Sevo_Nutra.pdf
FDA-2020-P-0947-0004_Letter_from_FDA_CDER_to_Hyman__Phelps___McNamara__.pdf
FDA-2020-P-1065-0004_Letter_from_FDA_CDER_to_B__Braun_Medical_Inc_.pdf
FDA-2020-P-1071-0002_Acknowledgment_Letter_from_FDA_DMS_to_Hyman__Phelp.pdf
FDA-2020-P-1072-0005_Response_Letter_from_FDA_CDER_to_Yiling_Pharmaceut.pdf
FDA-2020-P-1205-0002_Acknowledgment_Letter_from_FDA__DMS_to_Steptoe___J.pdf
FDA-2020-P-1220-0002_Acknowledgment_Letter_from_FDA_DMS_to_C_Laser_Inc.pdf
FDA-2020-P-1237-0002_Acknowledgment_Letter_from_FDA_DMS_to_Wiley_Rein__.pdf
FDA-2020-P-1238-0002_Acknowledgment_Letter_from_FDA_DMS_to_Cigar_Associ.pdf
FDA-2020-P-1239-0002_Acknowledgment_Letter_from_FDA_DMS_to_Wiley_Rein__.pdf
FDA-2020-P-1248-0002_Acknowledgement_Letter_from_FDA_DMS_to_Mark_Miles_.pdf
FDA-2020-P-1251-0002_Acknowledgment_Letter_from_FDA_DMS_to_Varun_Verada.pdf
FDA-2020-P-1260-0006_Interim_response_letter_from_FDA_CDER_to_Foley___L.pdf
FDA-2020-P-1297-0004_Response_Letter_from_FDA_CDER_to_Joe_DiNardo_Redac.pdf
FDA-2020-P-1305-0002_Acknowledgment_Letter_from_FDA_DMS_to_Dr__S__Alber.pdf
FDA-2020-P-1344-0007_Response_Letter_from_FDA_CDER_to_Lachman_Consultan.pdf
FDA-2020-P-1356-0002_Acknowledgment_Letter_from_FDA_DMS_to_Qilu_Pharmac.pdf
FDA-2020-P-1390-0002_Acknowledgment_Letter_from_FDA_DMS_to_Varun_Verada.pdf
FDA-2020-P-1403-0002_Acknowledgment_Letter_from_FDA_DMS_to_Hyman__Phelp.pdf
FDA-2020-P-1511-0011_Final_Response_Letter_from_FDA_CDER_to_Annora_Phar.pdf
FDA-2020-P-1549-0007_Final_Response_Letter_from_FDA_CDER_to_Windels_Mar.pdf
FDA-2020-P-1575-0002_Acknowledgment_Letter_from_FDA_DMS_to_Francis_E__O.pdf
FDA-2020-P-1605-0002_Acknowledgment_Letter_from_FDA_DMS_to_Novitium_Pha.pdf
FDA-2020-P-1641-0002_Acknowledgment_Letter_from_FDA_DMS_to_John_J_Colem.pdf
FDA-2020-P-1650-0004_Final_Response_to_Citizen_Petition_from_FDA_CDER_t.pdf
FDA-2020-P-1653-0002_Acknowledgment_Letter_from_FDA_DMS_to_Aurobindo_Ph.pdf
FDA-2020-P-1728-0002_Acknowledgment_Letter_from_FDA_DMS_to_Tenshi_Kaize.pdf
FDA-2020-P-1766-0002_Acknowledgment_Letter_from_FDA_DMS_to_The_Weinberg.pdf
FDA-2020-P-1771-0002_Acknowledgment_Letter_from_FDA_DMS_to_Windels_Marx.pdf
FDA-2020-P-1775-0002_Acknowledgment_Letter_from_FDA_DMS_to_Novitium_Pha.pdf
FDA-2020-P-1792-0002_Acknowledgment_Letter_from_FDA_DMS_to_Macleods_Pha.pdf
FDA-2020-P-1831-0039_Response_Letter_from_FDA_CDER_to_Meenal_Kheterpal_.pdf
FDA-2020-P-1844-0002_Acknowledgment_Letter_from_FDA_DMS_to_HYMAN__PHELP.pdf
FDA-2020-P-1849-0002_Acknowledgment_Letter_from_FDA_DMS_to_FOLEY___LARD.pdf
FDA-2020-P-1857-0002_Acknowledgment_Letter_from_FDA_DMS_to_SIRI___GLIMS.pdf
FDA-2020-P-1859-0002_Acknowledgment_Letter_from_FDA_DMS_to_GLAND_PHARMA.pdf
FDA-2020-P-1871-0002_Acknowledgment_Letter_from_FDA_DMS_to_Siri___Glims.pdf
FDA-2020-P-1873-0002_Acknowledgment_Letter_from_FDA_DMS_to_Bentley_Biom.pdf
FDA-2020-P-1878-0002_Acknowledgment_Letter_from_FDA_DMS_to_Foley___Lard.pdf
FDA-2020-P-1881-0005_Letter_to_The_Weinberg_Group_from_FDA_CDER.pdf
FDA-2020-P-1914-0002_Acknowledgment_Letter_from_FDA_DMS_to_Aurolife_Pha.pdf
FDA-2020-P-1919-0002_Acknowledgment_Letter_from_FDA_DMS_to_Acella_Pharm.pdf
FDA-2020-P-1991-0006_Response_Letter_from_FDA_CDER_to_Hyman__Phelps___M.pdf
FDA-2020-P-2003-0458_Memorandum_from_FDA_CFSAN_on_Health_and_Chemicals_.pdf
FDA-2020-P-2004-0002_Acknowledgment_Letter_from_FDA_DMS_to_Lachman_Cons.pdf
FDA-2020-P-2013-0002_Acknowledgment_Letter_from_FDA_DMS_to_Lachman_Cons.pdf
FDA-2020-P-2017-0002_Acknowledgment_Letter_from_FDA_DMS_to_Alston___Bir.pdf
FDA-2020-P-2033-0005_Interim_Response_Letter_from_FDA_DMS_to_Kentucky_D.pdf
FDA-2020-P-2048-0006_Response_Letter_from_FDA_CDER_to_Fresenius_Kabi_US.pdf
FDA-2020-P-2077-0002_Acknowledgment_Letter_from_FDA_DMS_to_The_Weinberg.pdf
FDA-2020-P-2102-0002_Acknowledgment_Letter_from_FDA_DMS_to_Aurora_Pharm.pdf
FDA-2020-P-2130-0002_Acknowledgment_Letter_from_FDA_DMS_to_Fresenius_Ka.pdf
FDA-2020-P-2132-0002_Acknowledgement_Letter_from_FDA_DMS_to_HYMAN__PHEL.pdf
FDA-2020-P-2134-0003_Interim_Response_Letter_from_FDA_CFSAN_to_Natural_.pdf
FDA-2020-P-2144-0002_Acknowledgment_Letter_from_FDA_DMS_to_Robert_van_O.pdf
FDA-2020-P-2146-0003_Response_Letter_from_FDA_CDER_to_BF_Innovation__In.pdf
FDA-2020-P-2166-0002_Acknowledgment_Letter_from_FDA_DMS_to_Emprise_Phar.pdf
FDA-2020-P-2174-0005_Agency_Response_from_FDA_CDER_to_Lachman_Consultin.pdf
FDA-2020-P-2175-0002_Acknowledgment_Letter_from_FDA_DMS_to_Lachman_Cons.pdf
FDA-2020-P-2187-0002_Acknowledgment_Letter_from_FDA_DMS_to_Lachman_Cons.pdf
FDA-2020-P-2234-0002_Acknowledgment_Letter_from_FDA_DMS_to_Ray_Law_Firm.pdf
FDA-2020-P-2245-0011_Letter_from_FDA_CDER_to_Camargo_Pharmaceutical_Ser.pdf
FDA-2020-P-2296-0026_Interim_response_from_FDA_CDER_to_Parenteral_Techn.pdf
FDA-2020-P-2299-0002_Acknowledgment_Letter_from_FDA_DMS_to_Zydus_Pharma.pdf
FDA-2020-P-2304-0005_Determination_from_FDA_CDER_to_Fresenius_Kabi_USA_.pdf
FDA-2020-P-2317-0004_Response_Letter_from_FDA_CDER_to_Baxter_Healthcare.pdf
FDA-2020-P-2318-0002_Acknowledgment_Letter_from_FDA_DMS_to_Lachman_Cons.pdf
